Healthcare and life sciences: navigating a hard Brexit scenario

In this session, we discuss the challenges that still need to be addressed by the healthcare and life science industry as a hard Brexit looks more likely.

We welcome Sandra Humphrey, Senior Legal Counsel at GlaxoSmithKline plc, who gives us a glimpse of GSK’s Brexit journey.

Also our international team of experts explore regulatory, IP, competition, tax and corporate issues to help you navigate these uncertain times.

> Watch the webinar on demand
> Download the slides

This document (and any information accessed through links in this document) is provided for information purposes only and does not constitute legal advice. Professional legal advice should be obtained before taking or refraining from any action as a result of the contents of this document.